PEARKO Therapeutics Inc.
$295,500.00 CAD
≈ 4 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- November 1, 2021 – March 31, 2024
- Reference
- nrc-cnrc:172-2021-2022-Q3-980844
Published purpose
PEARKO Therapeutics has been developing ApelinPlus (apelin analog) which can be a treatment for cardiovascular diseases. Currently, we are conducting preclinical testing of ApelinPlus, establishing required procedures, and preparing for regulatory filings with Health Canada, the Food and Drug Administration (FDA), and the European Medicines Agency (EMA).
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions